Welcome to our dedicated page for iShares Nasdaq 100 ETF news (Ticker: IQQ), a resource for investors and traders seeking the latest updates and insights on iShares Nasdaq 100 ETF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect iShares Nasdaq 100 ETF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of iShares Nasdaq 100 ETF's position in the market.
BlackRock (NYSE:BLK) plans to launch the iShares Nasdaq 100 ETF (Nasdaq:IQQ), giving cost-efficient access to Nasdaq-100 companies across technology, healthcare, consumer discretionary, and communication services. The ETF will have a gross expense ratio of 0.12%, waived to 0.10% through July 31, 2027.
IQQ will start with an initial NAV of $24 per share and is expected to trade on Nasdaq as early as July 9. The fund expands a $41 billion iShares Nasdaq-100 suite and leverages iShares’ global platform with more than $6 trillion in assets.